April 14, 2011
William P. Bro, Kidney Cancer Association At the Kidney Cancer foundation we’re constantly seeking new ways to ensure those with cancer have access to the best medical data and medicines possible. For the past 20 years, we have served as a source of support and information for individuals and their loved ones affected by kidney […]
February 16, 2011
Obtaining approval of new drugs can take as much money as $1 billion by the time research, manufacturing, safety and clinical trials have concluded. The pharmaceutical company patents the drug as soon as it is made, usually very early in the process of drug development. The patent protects that drug from being copied by anyone […]
February 14, 2011
Big pharmaceutical companies could face increased competition from generic drugmakers under two proposals put forth by the Obama administration on Monday despite earlier savings extracted from drugmakers as part of last year’s healthcare law. Read More
February 14, 2011
The Obama Administration’s fiscal 2012 budget document includes a call to reduce innovator biologics exclusivity from the 12 years just enacted as part of the health care reform law to 7 years, a number more in line with the position supported by advocates on the generic/drug/purchaser/consumer side of the debate. Read More
January 26, 2011
James Sykes, Director of Global Policy, The AIDS Institute The Hill Our nation’s political capital, Washington D.C. also has the notorious distinction of being the HIV and AIDS capital of the United States, with at least 3 percent of its residents infected. This rate is higher than most countries in West Africa and exceeds the […]
December 14, 2010
Biologic drugs can treat a variety of illnesses—including cancer and certain types of arthritis—imore effectively than traditional, chemical based products.
December 14, 2010
Biologic drugs are often referred to as ”miracle drugs“ for good reason…
November 15, 2010
Americans elected a new Congress on Nov. 2, but the voting booth wasn’t the only place where critical issues were at stake that day.
November 7, 2010
For cancer patients, what is the “acceptable risk” that a drug will pose safety risks or won’t work properly?
October 29, 2010
Patient safety is a core component of our medical system.
